Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issuance of Tranche 2 Loan Notes

15 May 2017 12:35

RNS Number : 1525F
Graphene NanoChem PLC
15 May 2017
 

For Immediate Release

15 May 2017

Graphene NanoChem PLC

("Graphene NanoChem" or the "Group")

Issuance of Tranche 2 Loan Notes

and

Update on Debt Rationalisation

Graphene NanoChem plc. (AIM:GRPH), the international provider of nanotechnology performance enhancing solutions for global industries, is pleased to announce that, pursuant to the Subscription Agreement dated 22 December 2016 for the issuance of up to £2.5m of Senior Unsecured Zero Coupon Convertible Loan Notes ("Loan Notes"), the Group has issued 40 Loan Notes ("Loan Notes") to Darwin Capital Limited ("Darwin") under Tranche 2 of the said agreement, effective 12 May 2017. The announcement of Tranche 1 was first announced on 23 December 2016.

The proceeds from the issuance will continue to support the working capital requirements of the Group as it continues to advance the progress of its business turnaround plan as previously announced, particularly in crystallizing opportunities in its water and enhanced polymer divisions.

For each £25,000 loan note issued, the Group will receive 90% of the Par Value, equivalent to £22,500 per individual loan note. The Group may redeem these Loan Notes at 105% of Par Value at any point. The Loan Notes are convertible at Darwin's election into new ordinary shares of 0.01p each in the Group ("Ordinary Shares") at the conversion price, being the lesser of 18.4375 pence per new Ordinary Share or 90% of the arithmetic average of five daily volume weighted average share price calculations selected by Darwin out of the twenty trading days prior to conversion. 

Darwin has also been issued with detachable warrants to subscribe for 1,355,932 new Ordinary Shares in the Group ("Warrants") at an exercise price of 18.4375 pence per new Ordinary Share. The Warrants can be exercised over a five-year period from the date of this announcement.

The Company has provided customary warranties, indemnities and undertakings, including customary negative pledges and anti-dilution protections, to Darwin in connection with the issue of the Loan Notes and Warrants. The Company has also paid an arrangement fee for Tranche 2 to Darwin in connection with the Loan Notes.

It is anticipated that Graphene Nanochem will receive net proceeds of approximately £850,000 pursuant to the second tranche of the Loan Notes.

Further announcements will be made in due course, including upon conversion.

Update on debt rationalization

The Company expects the successful debt restructuring exercise it has undertaken to now be unconditional by the end of the 2nd quarter 2017 post completion of the administrative process and other conditions precedent, including non-core asset sales, as previously announced.

The Group's CEO, Jespal Deol commented: "We are pleased with the Tranche 2 drawdown by Darwin further validating the continued progress that we have made in advancing our business including our water and enhanced polymer divisions. These funds raised will allow us to effectively focus on crystallizing the opportunities that we have been working on."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

For further information:

Graphene NanoChem

Tel: +603 2282 3080

Jespal Deol, Chief Executive Officer

 

 

 

Panmure Gordon (NOMAD and Broker)

 

Adam James / Tom Salvesen

Tel: +44 (0) 20 7886 2500

 

 

Yellow Jersey PR Limited (Media)

Tel: +44 (0)7544 275 882

Dominic Barretto / Harriet Jackson

 

 

About Graphene NanoChem

Graphene Nanochem plc (AIM: GRPH), is an international provider of nanotechnology performance enhancing solutions for global industries. The Group employs nanoprocesses and nanomaterials to design, engineer and enhance the performance of mainstream products for a wide range of industrial applications. It has established two major functional platforms in the energy and water sectors, and the Group, through partnerships with established industry players, is focused on building market opportunities in both sectors whilst continuing its developmental work in other strategic application areas of nanotechnology.

Headquartered in Malaysia, Graphene Nanochem was admitted to the AIM of the London Stock Exchange on 26 March 2013, following the reverse acquisition of Biofutures International plc, and trades under the symbol GRPH.L. To find out more, please visit www.graphenenanochem.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODEAFSSFDDXEFF
Date   Source Headline
16th Mar 20187:00 amRNSAcquisition Update and AIM Cancellation
16th Feb 20187:00 amRNSConfirmation of Resignation of Nomad and Broker
31st Jan 20181:47 pmRNSNotice of Resignation of Nomad and Broker
17th Jan 20189:24 amRNSResignation of Director
8th Jan 20182:50 pmRNSProposed Acquisition Update
30th Nov 20177:30 amRNSSuspension - Graphene Nanochem Plc
30th Nov 20177:00 amRNSProposed Acquisition and Suspension of Trading
12th Oct 20174:40 pmRNSSecond Price Monitoring Extn
12th Oct 20174:35 pmRNSPrice Monitoring Extension
11th Oct 20174:40 pmRNSSecond Price Monitoring Extn
11th Oct 20174:35 pmRNSPrice Monitoring Extension
29th Sep 201711:30 amRNSInterim Results
13th Sep 20179:31 amRNSHolding(s) in Company
13th Sep 20179:27 amRNSHolding(s) in Company
11th Sep 201712:07 pmRNSSecond Price Monitoring Extn
11th Sep 201712:02 pmRNSPrice Monitoring Extension
11th Sep 201711:45 amRNSConversion of Loan Notes and Issue of Equity
4th Sep 201710:15 amRNSConversion of loan note and issue of equity
2nd Aug 20171:20 pmRNSConversion of loan note and issue of equity
26th Jul 201711:30 amRNSResult of Annual General Meeting
4th Jul 20179:59 amRNSConversion of loan note and issue of equity
30th Jun 20177:03 amRNSPreliminary Results
27th Jun 20174:35 pmRNSPrice Monitoring Extension
23rd Jun 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSPolymer Division Paid Pilot
22nd May 201712:54 pmRNSPlatDrill Deployment In Myanmar
15th May 201712:35 pmRNSIssuance of Tranche 2 Loan Notes
12th Apr 20172:47 pmRNSConversion of loan note and issue of equity
3rd Apr 201711:47 amRNSConversion of Loan Note and Issue of Equity
31st Mar 20179:05 amRNSUpdate on Debt Rationalisation
8th Mar 201712:00 pmRNSConversion of loan note and issue of equity
3rd Mar 20177:00 amRNSCommercial deployment in Turkmenistan
20th Feb 20174:40 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
3rd Feb 20177:00 amRNSConversion of loan note and issue of equity
29th Dec 20164:19 pmRNSFurther information on 2015 report and accounts
28th Dec 20167:00 amRNSContract Win
23rd Dec 201612:35 pmRNSPrice Monitoring Extension
23rd Dec 20168:45 amRNSRestoration - Graphene NanoChem PLC
23rd Dec 20168:15 amRNSIssuance of Loan Notes and Resumption of Trading
6th Dec 20162:44 pmRNSResult of AGM
14th Nov 20165:04 pmRNSInterim Results
14th Nov 20165:01 pmRNSProposed Share Capital Reorganisation
14th Nov 20165:00 pmRNSPreliminary Results
31st Oct 20164:35 pmRNSUpdate on pending 2015 Annual Results
30th Sep 20163:20 pmRNSUpdate on 2015 Annual Results & 2016 Interims
1st Sep 20161:21 pmRNSUpdate on pending 2015 Annual Results
29th Jul 20167:00 amRNSUpdate on pending 2015 Annual Results
29th Jun 20167:30 amRNSSuspension - Graphene Nanochem Plc
29th Jun 20167:30 amRNSStatement re. Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.